- Home
- CBLL vs LXRX Comparison
CBLL vs LXRX Comparison
Compare CBLL & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- LXRX
- Stock Information
- Founded
- CBLL 2014
- LXRX 1995
- Country
- CBLL United States
- LXRX United States
- Employees
- CBLL N/A
- LXRX N/A
- Industry
- CBLL
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CBLL
- LXRX Health Care
- Exchange
- CBLL Nasdaq
- LXRX Nasdaq
- Market Cap
- CBLL 433.7M
- LXRX 428.8M
- IPO Year
- CBLL 2024
- LXRX 2000
- Fundamental
- Price
- CBLL $11.51
- LXRX $1.13
- Analyst Decision
- CBLL Strong Buy
- LXRX Buy
- Analyst Count
- CBLL 6
- LXRX 5
- Target Price
- CBLL $33.00
- LXRX $3.23
- AVG Volume (30 Days)
- CBLL 260.6K
- LXRX 1.8M
- Earning Date
- CBLL 11-11-2025
- LXRX 11-11-2025
- Dividend Yield
- CBLL N/A
- LXRX N/A
- EPS Growth
- CBLL N/A
- LXRX N/A
- EPS
- CBLL N/A
- LXRX N/A
- Revenue
- CBLL $77,419,000.00
- LXRX $58,432,000.00
- Revenue This Year
- CBLL $35.06
- LXRX N/A
- Revenue Next Year
- CBLL $28.56
- LXRX N/A
- P/E Ratio
- CBLL N/A
- LXRX N/A
- Revenue Growth
- CBLL 42.16
- LXRX 1504.83
- 52 Week Low
- CBLL $10.01
- LXRX $0.28
- 52 Week High
- CBLL $32.75
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- CBLL 39.86
- LXRX 52.37
- Support Level
- CBLL $11.18
- LXRX $1.03
- Resistance Level
- CBLL $12.14
- LXRX $1.15
- Average True Range (ATR)
- CBLL 0.49
- LXRX 0.06
- MACD
- CBLL 0.13
- LXRX -0.00
- Stochastic Oscillator
- CBLL 21.75
- LXRX 58.82
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.